N/A N=90 The Effect of Lavender on Sleep and Balance
Sleeping Disorders · Nursing
Primary: Pittsburgh Sleep Quality İndex (PSQI) — 6.11; 5.82 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=3 A Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in France
Acid Sphingomyelinase Deficiency
Primary: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 3; 0 Participants
Phase 4 N=288 A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder
Primary: Part A: Change From Baseline in the Cambridge Neuropsychological Test Automated Battery (CANTAB) Reaction Time (RTI) Task at Week 18 — -7.1; -9.2; -5.1; 5.3 msec
N/A N=76 Study of Brain, Reward, and Kids' Eating
Obesity, Childhood · Eating Behavior
Primary: Child Body Mass Index — 17.83; 18.78 kg/m-squred
Phase 4 N=60 Weekly Doxycycline DOT for STI Prevention Among Cisgender Women Taking HIV PrEP in Kisumu, Kenya
STI
Primary: doxyPEP DOT Adherence — 1417 Doses
N/A N=21 Compassion-Based Resiliency Training (CBRT) Intervention on Racism-based Stress
Racism · Stress, Psychological
Primary: Feasibility of Study — 19 Participants
Phase 2 N=15 Letermovir for CMV Prevention After Lung Transplantation
Lung Transplant · CMV
Primary: Occurrence of CMV Infection or Disease During Prophylaxis — 0 Participants
N/A N=43 Preventing Overdose Using Information and Data From the Environment
Opioid Overdose · Drug Overdose
Primary: Cumulative Incidence of Accidental Fatal and Non-Fatal Drug Overdoses — 43.5; 37.1 Overdoses per 10,000 residents
Phase 3 N=87 Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age
Chagas Disease
Primary: Global PCR (Conventional PCR and Real-time Quantitative PCR) Immediately After the End of Treatment. — 16; 20 Participants
N/A N=30 Cimarrón Bean Extrudate Solution on Platelet Function and Biochemical Parameters
Postprandial Glucose · Platelet Activation
Primary: Change in Platelet Reactivity After Acute Consumption of SPVCE — 0.23; 0.16; 0.05; 0.05 μM — p=0.02
N/A N=148 A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Foot/Ankle
Insufficiency Fractures · Stress Fracture · Stress Fracture, Ankle, Foot and Toes
Primary: Foot Function Index-Revised (FFI-R) Short Form Score at 24 Months — 42.8; 43.0; 39.6 Percentage scale
N/A N=116 Perioperative Mental Health in Orthopedic Surgery
Orthopedic Surgery · Older Adults · Depression
Primary: PHQ-ADS (Patient Health Questionnaire Anxiety and Depression Scale) — 16.84; 19.35; 11.26; 13.09 Points
Phase 2 N=500 A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: Change From Baseline in Glycosylated Haemoglobin (HbA1c) — -2.3; -2.2; -2.2; -2.3 Percentage point of HbA1c — p=<0.0001
Phase 1 N=12 Phase Ib of L-NMMA and Pembrolizumab
Non-Small Cell Lung Cancer · Malignant Melanoma · Head and Neck Squamous Cell Carcinoma
Primary: Maximum Tolerated Dose (MTD) — 20 mg/kg
N/A N=105 Behavioral Activation and Medication Optimization In Older Adults Undergoing Cardiac Procedures
Cardiac Surgery · Older Adults · Depression
Primary: PHQ-ADS — 18.39; 18.59; 12.33; 11.67 Points